| Year |
Citation |
Score |
| 2020 |
Fiala EM, Ortiz MV, Kennedy JA, Glodzik D, Fleischut MH, Duffy KA, Hathaway ER, Heaton T, Gerstle JT, Steinherz P, Shukla N, McNeer N, Tkachuk K, Bouvier N, Cadoo K, ... ... Kentsis A, et al. 11p15.5 epimutations in children with Wilms tumor and hepatoblastoma detected in peripheral blood. Cancer. PMID 32320050 DOI: 10.1002/Cncr.32907 |
0.738 |
|
| 2019 |
Wan L, Chong S, Xuan F, Liang A, Cui X, Gates L, Carroll TS, Li Y, Feng L, Chen G, Wang SP, Ortiz MV, Daley SK, Wang X, Xuan H, ... Kentsis A, et al. Impaired cell fate through gain-of-function mutations in a chromatin reader. Nature. PMID 31853060 DOI: 10.1038/S41586-019-1842-7 |
0.375 |
|
| 2019 |
Ortiz MV, Ahmed S, Burns M, Henssen AG, Hollmann TJ, MacArthur I, Gunasekera S, Gaewsky L, Bradwin G, Ryan J, Letai A, He Y, Naranjo A, Chi YY, LaQuaglia M, ... ... Kentsis A, et al. Prohibitin is a prognostic marker and therapeutic target to block chemotherapy resistance in Wilms' tumor. Jci Insight. 4. PMID 31391345 DOI: 10.1172/Jci.Insight.127098 |
0.323 |
|
| 2019 |
Sher F, Hossain M, Seruggia D, Schoonenberg VAC, Yao Q, Cifani P, Dassama LMK, Cole MA, Ren C, Vinjamur DS, Macias-Trevino C, Luk K, McGuckin C, Schupp PG, Canver MC, ... ... Kentsis A, et al. Rational targeting of a NuRD subcomplex guided by comprehensive in situ mutagenesis. Nature Genetics. PMID 31253978 DOI: 10.1038/S41588-019-0453-4 |
0.343 |
|
| 2019 |
MacArthur IC, Bei Y, Dorado García H, Ortiz MV, Toedling J, Klironomos F, Rolff J, Eggert A, Schulte JH, Kentsis A, Henssen AG. Prohibitin promotes de-differentiation and is a potential therapeutic target in neuroblastoma. Jci Insight. 5. PMID 30998507 DOI: 10.1172/Jci.Insight.127130 |
0.332 |
|
| 2019 |
McNeer NA, Philip J, Geiger H, Ries RE, Lavallée VP, Walsh M, Shah M, Arora K, Emde AK, Robine N, Alonzo TA, Kolb EA, Gamis AS, Smith M, Gerhard DS, ... ... Kentsis A, et al. Genetic mechanisms of primary chemotherapy resistance in pediatric acute myeloid leukemia. Leukemia. PMID 30760869 DOI: 10.1038/S41375-019-0402-3 |
0.759 |
|
| 2019 |
McNeer N, Philip J, Geiger H, Ries RE, Lavallee V, Walsh M, Shah M, Arora K, Emde A, Robine N, Alonzo TA, Kolb EA, Gamis AS, Smith M, Gerhard DS, ... ... Kentsis A, et al. Abstract 2870: Genetic mechanisms of primary chemotherapy resistance in pediatric acute myeloid leukemia Cancer Research. DOI: 10.1158/1538-7445.Sabcs18-2870 |
0.741 |
|
| 2018 |
Henssen AG, Kentsis A. Emerging functions of DNA transposases and oncogenic mutators in childhood cancer development. Jci Insight. 3. PMID 30333322 DOI: 10.1172/Jci.Insight.123172 |
0.348 |
|
| 2018 |
Cifani P, Dhabaria A, Chen Z, Yoshimi A, Kawaler E, Abdel-Wahab O, Poirier JT, Kentsis A. ProteomeGenerator: A framework for comprehensive proteomics based on de novo transcriptome assembly and high-accuracy peptide mass spectral matching. Journal of Proteome Research. PMID 30295032 DOI: 10.1021/Acs.Jproteome.8B00295 |
0.312 |
|
| 2018 |
Johnson DC, Taabazuing CY, Okondo MC, Chui AJ, Rao SD, Brown FC, Reed C, Peguero E, de Stanchina E, Kentsis A, Bachovchin DA. DPP8/DPP9 inhibitor-induced pyroptosis for treatment of acute myeloid leukemia. Nature Medicine. PMID 29967349 DOI: 10.1038/S41591-018-0082-Y |
0.346 |
|
| 2018 |
Hoshii T, Cifani P, Feng Z, Huang CH, Koche R, Chen CW, Delaney CD, Lowe SW, Kentsis A, Armstrong SA. A Non-catalytic Function of SETD1A Regulates Cyclin K and the DNA Damage Response. Cell. 172: 1007-1021.e17. PMID 29474905 DOI: 10.1016/J.Cell.2018.01.032 |
0.317 |
|
| 2018 |
Gutierrez A, Kentsis A. Acute myeloid/T-lymphoblastic leukaemia (AMTL): a distinct category of acute leukaemias with common pathogenesis in need of improved therapy. British Journal of Haematology. PMID 29441563 DOI: 10.1111/Bjh.15129 |
0.319 |
|
| 2018 |
Brown FC, Still E, Koche RP, Yim CY, Takao S, Cifani P, Reed C, Gunasekera S, Ficarro SB, Romanienko P, Mark W, McCarthy C, de Stanchina E, Gonen M, Seshan V, ... ... Kentsis A, et al. MEF2C phosphorylation is required for chemotherapy resistance in acute myeloid leukemia. Cancer Discovery. PMID 29431698 DOI: 10.1158/2159-8290.Cd-17-1271 |
0.36 |
|
| 2018 |
Ramaswamy K, Forbes L, Minuesa G, Gindin T, Brown F, Kharas MG, Krivtsov AV, Armstrong SA, Still E, de Stanchina E, Knoechel B, Koche R, Kentsis A. Peptidomimetic blockade of MYB in acute myeloid leukemia. Nature Communications. 9: 110. PMID 29317678 DOI: 10.1038/s41467-017-02618-6 |
0.742 |
|
| 2018 |
Takao S, Koche R, Cifani P, Ser Z, Kentsis A. Functional Profiling of Patient AML Stem Cells Reveals Mechanisms of Epigenetic Plasticity Controlling Therapy Resistance Blood. 132: 1318-1318. DOI: 10.1182/Blood-2018-99-114433 |
0.371 |
|
| 2018 |
Cifani P, Dogan A, Solit DB, Kentsis A. Abstract 5650: Functional proteomics for precise cancer diagnosis and therapy using the MSK Quantitative Cancer Proteomics Atlas Cancer Research. 78: 5650-5650. DOI: 10.1158/1538-7445.Am2018-5650 |
0.381 |
|
| 2017 |
Henssen AG, Reed C, Jiang E, Garcia HD, von Stebut J, MacArthur IC, Hundsdoerfer P, Kim JH, de Stanchina E, Kuwahara Y, Hosoi H, Ganem NJ, Dela Cruz F, Kung AL, Schulte JH, ... ... Kentsis A, et al. Therapeutic targeting of PGBD5-induced DNA repair dependency in pediatric solid tumors. Science Translational Medicine. 9. PMID 29093183 DOI: 10.1126/Scitranslmed.Aam9078 |
0.355 |
|
| 2017 |
Henssen AG, Koche R, Zhuang J, Jiang E, Reed C, Eisenberg A, Still E, MacArthur IC, Rodríguez-Fos E, Gonzalez S, Puiggròs M, Blackford AN, Mason CE, de Stanchina E, Gönen M, ... ... Kentsis A, et al. PGBD5 promotes site-specific oncogenic mutations in human tumors. Nature Genetics. PMID 28504702 DOI: 10.1038/Ng.3866 |
0.349 |
|
| 2017 |
Ortiz MV, Magnan H, Slotkin EK, Ambati SR, Chou AJ, Wexler LH, Meyers PA, Walsh MF, Heaton T, Girardi LN, Wolden SL, Price AP, Kennedy JA, Zehir A, Hameed M, ... ... Kentsis A, et al. Intracardiac Low-grade Sarcoma Following Treatment for Ewing Sarcoma. Journal of Pediatric Hematology/Oncology. PMID 28060130 DOI: 10.1097/Mph.0000000000000754 |
0.322 |
|
| 2017 |
Ortiz MV, Burns M, Eisenberg A, Ahmed S, Gaewsky L, Bradwin G, Cifani P, Henssen A, Macarthur I, LaQuaglia M, Letai A, Naranjo A, Gadd S, Chi Y, Dome J, ... ... Kentsis A, et al. Abstract 708: Prohibitin is a prognostic marker of treatment failure and therapeutic target to block chemotherapy resistance in Wilms tumor Cancer Research. 77: 708-708. DOI: 10.1158/1538-7445.Am2017-708 |
0.355 |
|
| 2016 |
Brown FC, Cifani P, Drill E, He J, Still E, Zhong S, Balasubramanian S, Pavlick D, Yilmazel B, Knapp KM, Alonzo TA, Meshinchi S, Stone RM, Kornblau SM, Marcucci G, ... ... Kentsis A, et al. Genomics of primary chemoresistance and remission induction failure in paediatric and adult acute myeloid leukaemia. British Journal of Haematology. PMID 27766616 DOI: 10.1111/Bjh.14413 |
0.357 |
|
| 2016 |
Mathias MD, Chou AJ, Meyers P, Shukla N, Hameed M, Agaram N, Wang L, Berger MF, Walsh M, Kentsis A. Osteosarcoma With Apparent Ewing Sarcoma Gene Rearrangement. Journal of Pediatric Hematology/Oncology. 38: e166-e168. PMID 27352193 DOI: 10.1097/Mph.0000000000000553 |
0.329 |
|
| 2016 |
Brown FC, Still E, Cifani P, Reed C, Ficarro S, He J, Koche R, Bhola P, Romanienko P, Mark W, Krivtsov AV, Letai A, Gray N, Marto J, Armstrong SA, ... Kentsis A, et al. Aberrant Phosphorylation of MEF2C Is Dispensable for Hematopoiesis, and Induces Chemotherapy Resistance and Susceptibility to MARK Kinase Inhibition Therapy in Acute Myeloid Leukemia Blood. 128: 436-436. DOI: 10.1182/Blood.V128.22.436.436 |
0.383 |
|
| 2016 |
Hoshii T, Cifani P, Nakadai T, Feng Z, Huang C, Koche R, Delaney CD, Chen CD, Lowe SW, Roeder R, Kentsis A, Armstrong SA. Non-Catalytic Role of SETD1A Regulates DNA Repair in Leukemia Blood. 128: 434-434. DOI: 10.1182/Blood.V128.22.434.434 |
0.349 |
|
| 2016 |
Wang M, Ser Z, Rao S, Fahl S, Zhang Y, Peri S, Kentsis A, Wiest DL. Ribosomal Protein Rpl22 Regulates Development and Transformation Via Altering RNA Processing Blood. 128: 3878-3878. DOI: 10.1182/Blood.V128.22.3878.3878 |
0.351 |
|
| 2016 |
Kobos R, He J, Steinherz PG, Curran KJ, Renaud TM, Forlenza C, Boulad F, Prockop S, Knapp KM, Walsh M, Roshal M, Wang L, Papaemmanuil E, Dogan A, Zhong S, ... ... Kentsis A, et al. Comprehensive Genomic Profiling for Improved Diagnosis and Therapy of Pediatric Acute Leukemias Blood. 128: 1605-1605. DOI: 10.1182/Blood.V128.22.1605.1605 |
0.339 |
|
| 2015 |
Laszlo GS, Alonzo TA, Gudgeon CJ, Harrington KH, Kentsis A, Gerbing RB, Wang YC, Ries RE, Raimondi SC, Hirsch BA, Gamis AS, Meshinchi S, Walter RB. High expression of myocyte enhancer factor 2C (MEF2C) is associated with adverse-risk features and poor outcome in pediatric acute myeloid leukemia: a report from the Children's Oncology Group. Journal of Hematology & Oncology. 8: 115. PMID 26487643 DOI: 10.1182/Blood.V126.23.2570.2570 |
0.315 |
|
| 2015 |
Etchin J, Montero J, Berezovskaya A, Le BT, Kentsis A, Christie AL, Conway AS, Chen WC, Reed C, Mansour MR, Ng CE, Adamia S, Rodig SJ, Galinsky IA, Stone RM, et al. Activity of a selective inhibitor of nuclear export, selinexor (KPT-330), against AML-Initiating cells engrafted into immunosuppressed NSG mice. Leukemia. PMID 26202935 DOI: 10.1038/Leu.2015.194 |
0.382 |
|
| 2015 |
Ramaswamy K, Spitzer B, Kentsis A. Therapeutic Re-Activation of Protein Phosphatase 2A in Acute Myeloid Leukemia. Frontiers in Oncology. 5: 16. PMID 25699237 DOI: 10.3389/Fonc.2015.00016 |
0.384 |
|
| 2015 |
Mansour MR, Reed C, Eisenberg AR, Tseng JC, Twizere JC, Daakour S, Yoda A, Rodig SJ, Tal N, Shochat C, Berezovskaya A, DeAngelo DJ, Sallan SE, Weinstock DM, Izraeli S, ... ... Kentsis A, et al. Targeting oncogenic interleukin-7 receptor signalling with N-acetylcysteine in T cell acute lymphoblastic leukaemia. British Journal of Haematology. 168: 230-8. PMID 25256574 DOI: 10.1111/Bjh.13115 |
0.375 |
|
| 2015 |
Brown F, Still E, Cifani P, Ficarro S, Pouliot G, Drill E, Gonen M, He J, Balasubramanian S, Zhong S, Pavlick D, Yilmazel B, Krivtsov AV, Alonzo TA, Meshinchi S, ... ... Kentsis A, et al. Genomic and Proteomic Analysis of Primary Chemoresistance and Induction Failure in Acute Myeloid Leukemia Blood. 126: 88-88. DOI: 10.1182/Blood.V126.23.88.88 |
0.403 |
|
| 2015 |
Cifani P, Shakiba M, Brown F, Dhabaria A, Bauer DE, Kentsis A. Functional Proteomics of Regulatory and Epigenetic Signaling in Normal and Malignant Hematopoiesis Blood. 126: 4972-4972. DOI: 10.1182/Blood.V126.23.4972.4972 |
0.353 |
|
| 2015 |
Etchin J, Le BT, Berezovskaya A, Conway AS, Chen WC, Kentsis A, Mansour MR, Stone RM, Galinsky IA, DeAngelo DJ, McCauley D, Kauffman M, Shacham S, Wang JC, Kung AL, et al. Abstract 4445: Selective inhibitor of nuclear exporter CRM1/XPO1, Selinexor (KPT-330), exhibits remarkable activity against AML leukemia-initiating cells while sparing normal hematopoietic cells Cancer Research. 75: 4445-4445. DOI: 10.1158/1538-7445.Am2015-4445 |
0.71 |
|
| 2015 |
Henssen A, Eisenberg A, Jiang E, Henaff E, Koche R, Burns M, Carson JR, Nanjangud G, Still E, Gandara J, Cifani P, Dhabaria A, Huang X, Stanchina Ed, Mullen E, ... ... Kentsis A, et al. Abstract 1103: Human tumorigenesis induced by endogenous DNA transposase Cancer Research. 75: 1103-1103. DOI: 10.1158/1538-7445.Am2015-1103 |
0.366 |
|
| 2014 |
Gutierrez A, Pan L, Groen RWJ, Baleydier F, Kentsis A, Marineau J, Grebliunaite R, Kozakewich E, Reed C, Pflumio F, Poglio S, Uzan B, Clemons P, VerPlank L, An F, et al. Phenothiazines induce PP2A-mediated apoptosis in T cell acute lymphoblastic leukemia Journal of Clinical Investigation. 124: 644-655. PMID 24401270 DOI: 10.1172/Jci65093 |
0.34 |
|
| 2014 |
Etchin J, Le BT, Kentsis A, Mansour MR, Berezovskaya A, Stone RM, Galinsky I, DeAngelo DJ, McCauley D, Kauffman M, Shacham S, Wang JCY, Kung AL, Look AT. Selective Inhibitor of Nuclear Export (SINE), Selinexor (KPT-330), Shows Remarkable Activity Against AML Leukemia-Initiating Cells Blood. 124: 995-995. DOI: 10.1182/Blood.V124.21.995.995 |
0.376 |
|
| 2014 |
Gutierrez A, Pan L, Groen R, Baleydier F, Kentsis A, Marineau J, Grebliunaite R, Kozakewich E, Reed C, Pflumio F, Poglio S, Uzan B, Clemons P, Verplank L, An F, et al. Abstract IA8: A new class of drugs active in T-ALL is revealed in a zebrafish screen Molecular Cancer Research. 12. DOI: 10.1158/1557-3125.Modorg-Ia8 |
0.342 |
|
| 2013 |
Etchin J, Sanda T, Mansour MR, Kentsis A, Montero J, Le BT, Christie AL, McCauley D, Rodig SJ, Kauffman M, Shacham S, Stone R, Letai A, Kung AL, Thomas Look A. KPT-330 inhibitor of CRM1 (XPO1)-mediated nuclear export has selective anti-leukaemic activity in preclinical models of T-cell acute lymphoblastic leukaemia and acute myeloid leukaemia. British Journal of Haematology. 161: 117-27. PMID 23373539 DOI: 10.1111/Bjh.12231 |
0.366 |
|
| 2013 |
Etchin J, Sun Q, Kentsis A, Farmer A, Zhang ZC, Sanda T, Mansour MR, Barcelo C, McCauley D, Kauffman M, Shacham S, Christie AL, Kung AL, Rodig SJ, Chook YM, et al. Antileukemic activity of nuclear export inhibitors that spare normal hematopoietic cells. Leukemia. 27: 66-74. PMID 22847027 DOI: 10.1038/Leu.2012.219 |
0.365 |
|
| 2013 |
Etchin J, Le BT, Kentsis A, Stone RM, McCauley D, Kauffman M, Shacham S, Wang JCY, Kung AL, Look AT. Novel Inhibitors Of CRM1/XPO1 Nuclear Exporter Exhibit Striking Activity Against AML “primagrafts,” Including AML Leukemia Initiating Cells, While Sparing Normal Hematopoietic Cells Blood. 122: 3932-3932. DOI: 10.1182/Blood.V122.21.3932.3932 |
0.395 |
|
| 2013 |
Reed C, Eisenberg A, Tseng J, Yoda A, Rodig SJ, DeAngelo DJ, Sallan SE, Weinstock DM, Izraeli S, Kung AL, Kentsis A, Look T. Targeting Oncogenic Interleukein-7 Receptor Signaling With N-Acetylcysteine In T-Cell Acute Lymphoblastic Leukemia Blood. 122: 2535-2535. DOI: 10.1182/Blood.V122.21.2535.2535 |
0.7 |
|
| 2012 |
Kentsis A, Reed C, Rice KL, Sanda T, Rodig SJ, Tholouli E, Christie A, Valk PJ, Delwel R, Ngo V, Kutok JL, Dahlberg SE, Moreau LA, Byers RJ, Christensen JG, et al. Autocrine activation of the MET receptor tyrosine kinase in acute myeloid leukemia. Nature Medicine. 18: 1118-22. PMID 22683780 DOI: 10.1038/Nm.2819 |
0.375 |
|
| 2012 |
Etchin J, Kentsis A, Sanda T, Kung AL, Stone RM, McCauley D, Kauffman M, Shacham S, Look AT. Evaluation of KPT-SINE (Selective Inhibitors of CRM1-Mediated Nuclear Export) in AML and T-ALL. Journal of Clinical Oncology. 30: e13586-e13586. DOI: 10.1200/Jco.2012.30.15_Suppl.E13586 |
0.373 |
|
| 2012 |
Gutierrez A, Kentsis A, Pan L, Baleydier F, Marineau J, Grebliunaite R, Kozakewich E, Reed C, Pflumio F, Poglio S, Uzan B, Clemons PA, VerPlank L, An WF, Burbank J, et al. Phenothiazines Induce Apoptosis in T-Cell Acute Lymphoblastic Leukemia by Activating the Phosphatase Activity of the PP2A Tumor Suppressor Blood. 120: 3558-3558. DOI: 10.1182/Blood.V120.21.3558.3558 |
0.36 |
|
| 2011 |
Gutierrez A, Kentsis A, Sanda T, Holmfeldt L, Chen SC, Zhang J, Protopopov A, Chin L, Dahlberg SE, Neuberg DS, Silverman LB, Winter SS, Hunger SP, Sallan SE, Zha S, et al. The BCL11B tumor suppressor is mutated across the major molecular subtypes of T-cell acute lymphoblastic leukemia. Blood. 118: 4169-73. PMID 21878675 DOI: 10.1182/Blood-2010-11-318873 |
0.336 |
|
| 2011 |
Etchin J, Kentsis A, Sanda T, Kung AL, Stone RM, McCauley D, Kauffman M, Shacham S, Look T. KPT-SINE, a Potent, Small Molecule Inhibitor of CRM1-Dependent Nuclear-Cytoplasmic Shuttling, with Potent Activity Against T-ALL and AML Blood. 118: 2622-2622. DOI: 10.1182/Blood.V118.21.2622.2622 |
0.698 |
|
| 2011 |
Kentsis A, Sanda T, Reed C, Rodig SJ, Tholouli E, Ngo V, Kutok JL, Dahlberg SE, Moreau LA, Vande Woude G, Christensen J, Byers R, Kung AL, Staudt LM, Look T. Combined Targeting of the MET and FGF Receptor Tyrosine Kinases Induces Sustained AML Cell Death by Preventing Compensatory Upregulation of HGF in Response to MET Kinase Inhibition Blood. 118: 1405-1405. DOI: 10.1182/Blood.V118.21.1405.1405 |
0.687 |
|
| 2010 |
Gutierrez A, Kentsis A, Sanda T, Etchin J, Protopopov A, Zhang J, Chin L, Silverman LB, Winter S, Hunger S, Sallan SE, Zha S, Alt F, Look AT. The BCL11B Tumor Suppressor Is Mutated In Human T-Cell Acute Lymphoblastic Leukemia Blood. 116: 4177-4177. DOI: 10.1182/Blood.V116.21.4177.4177 |
0.348 |
|
| 2010 |
Kentsis A, Sanda T, Ngo V, Rodig SJ, Kutok J, Tholouli E, Byers R, Woude GV, Kung AL, Staudt LM, Look AT. Aberrant Expression of Hepatocyte Growth Factor Induces Autocrine MET Activation Providing a Novel Therapeutic Target In Acute Myeloid Leukemia. Blood. 116: 1042-1042. DOI: 10.1182/Blood.V116.21.1042.1042 |
0.386 |
|
| 2009 |
Kentsis A, Monigatti F, Dorff K, Campagne F, Bachur R, Steen H. Urine proteomics for profiling of human disease using high accuracy mass spectrometry. Proteomics. Clinical Applications. 3: 1052-1061. PMID 21127740 DOI: 10.1002/Prca.200900008 |
0.301 |
|
| 2007 |
Kentsis A, Gindin T, Mezei M, Osman R. Calculation of the free energy and cooperativity of protein folding Plos One. 2. PMID 17505540 DOI: 10.1371/Journal.Pone.0000446 |
0.74 |
|
| 2005 |
Kentsis A, Mezei M, Osman R. Origin of the sequence-dependent polyproline II structure in unfolded peptides Proteins: Structure, Function and Genetics. 61: 769-776. PMID 16193481 DOI: 10.1002/Prot.20655 |
0.524 |
|
| 2005 |
Ulane CM, Kentsis A, Cruz CD, Parisien JP, Schneider KL, Horvath CM. Composition and assembly of STAT-targeting ubiquitin ligase complexes: paramyxovirus V protein carboxyl terminus is an oligomerization domain. Journal of Virology. 79: 10180-9. PMID 16051811 DOI: 10.1128/Jvi.79.16.10180-10189.2005 |
0.313 |
|
| 2005 |
Topisirovic I, Kentsis A, Perez JM, Guzman ML, Jordan CT, Borden KL. Eukaryotic translation initiation factor 4E activity is modulated by HOXA9 at multiple levels. Molecular and Cellular Biology. 25: 1100-12. PMID 15657436 DOI: 10.1128/Mcb.25.3.1100-1112.2005 |
0.614 |
|
| 2005 |
Miller F, Kentsis A, Osman R, Pan ZQ. Inactivation of VHL by tumorigenic mutations that disrupt dynamic coupling of the pVHL·hypoxia-inducible transcription factor-1α complex Journal of Biological Chemistry. 280: 7985-7996. PMID 15611064 DOI: 10.1074/Jbc.M413160200 |
0.504 |
|
| 2004 |
Kentsis A, Topisirovic I, Culjkovic B, Shao L, Borden KLB. Ribavirin suppresses elF4E-mediated oncogenic transformation by physical mimicry of the 7-methyl guanosine mRNA cap Proceedings of the National Academy of Sciences of the United States of America. 101: 18105-18110. PMID 15601771 DOI: 10.1073/Pnas.0406927102 |
0.343 |
|
| 2004 |
Kentsis A, Mezei M, Gindin T, Osman R. Unfolded State of Polyalanine Is a Segmented Polyproline II Helix Proteins: Structure, Function and Genetics. 55: 493-501. PMID 15103613 DOI: 10.1002/Prot.20051 |
0.738 |
|
| 2004 |
Pan ZQ, Kentsis A, Dias DC, Yamoah K, Wu K. Nedd8 on cullin: Building an expressway to protein destruction Oncogene. 23: 1985-1997. PMID 15021886 DOI: 10.1038/Sj.Onc.1207414 |
0.314 |
|
| 2003 |
Kentsis A, Mezei M, Osman R. MC-PHS: A Monte Carlo implementation of the primary hydration shell for protein folding and design Biophysical Journal. 84: 805-815. PMID 12547765 DOI: 10.1016/S0006-3495(03)74900-5 |
0.485 |
|
| 2001 |
Kentsis A, Dwyer EC, Perez JM, Sharma M, Chen A, Pan ZQ, Borden KLB. The RING domains of the promyelocytic leukemia protein PML and the arenaviral protein Z repress translation by directly inhibiting translation initiation factor eIF4E Journal of Molecular Biology. 312: 609-623. PMID 11575918 DOI: 10.1006/Jmbi.2001.5003 |
0.326 |
|
| 2000 |
Krantz BA, Moran LB, Kentsis A, Sosnick TR. D/H amide kinetic isotope effects reveal when hydrogen bonds form during protein folding. Nature Structural Biology. 7: 62-71. PMID 10625430 DOI: 10.1038/71265 |
0.696 |
|
| 1999 |
Moran LB, Schneider JP, Kentsis A, Reddy GA, Sosnick TR. Transition state heterogeneity in GCN4 coiled coil folding studied by using multisite mutations and crosslinking. Proceedings of the National Academy of Sciences of the United States of America. 96: 10699-704. PMID 10485889 DOI: 10.1073/Pnas.96.19.10699 |
0.564 |
|
| 1998 |
Kentsis A, Sosnick TR. Trifluoroethanol promotes helix formation by destabilizing backbone exposure: desolvation rather than native hydrogen bonding defines the kinetic pathway of dimeric coiled coil folding. Biochemistry. 37: 14613-22. PMID 9772190 DOI: 10.1021/Bi981641Y |
0.548 |
|
| Show low-probability matches. |
